| 1 | International consensus on methotrexate dosing for patients with atopic dermatitis: An <scp>eDelphi</scp> study | 2.3 | 4 | Citations (PDF) |
| 2 | Treat‐to‐target in dermatology: A scoping review and International Eczema Council survey on the approach in atopic dermatitis | 2.3 | 13 | Citations (PDF) |
| 3 | <scp>Real‐world</scp> clinical, psychosocial and economic burden of atopic dermatitis: Results from a multicountry study | 2.3 | 50 | Citations (PDF) |
| 4 | Living with a rare disease: a patient perspective of life with trimethylaminuria | 1.2 | 0 | Citations (PDF) |
| 5 | Impact of climate change on atopic dermatitis: A review by the International Eczema Council | 9.5 | 33 | Citations (PDF) |
| 6 | Preclinical Atopic Dermatitis Skin in Infants: An Emerging Research Area | 2.3 | 7 | Citations (PDF) |
| 7 | Lin<sup>−</sup>CD117<sup>+</sup>CD34<sup>+</sup>FcεRI<sup>+</sup> progenitor cells are increased in chronic spontaneous urticaria and predict clinical responsiveness to anti‐<scp>IgE</scp> therapy | 9.5 | 6 | Citations (PDF) |
| 8 | Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration | 9.5 | 23 | Citations (PDF) |
| 9 | An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024 | 1.8 | 19 | Citations (PDF) |
| 10 | Genotypes and phenotypes heterogeneity in PIK3CA-related overgrowth spectrum and overlapping conditions: 150 novel patients and systematic review of 1007 patients with PIK3CA pathogenetic variants | 3.9 | 31 | Citations (PDF) |
| 11 | Early initiation of short‐term emollient use for the prevention of atopic dermatitis in high‐risk infants—The STOP‐AD randomised controlled trial | 9.5 | 81 | Citations (PDF) |
| 12 | Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis | 2.8 | 9 | Citations (PDF) |
| 13 | Novel mixed-method, inclusive protocol involving global key stakeholders, including carers as experts, to co-develop relevant Caregiver-Reported Outcome Domains (CRODs) in skin disease | 2.0 | 3 | Citations (PDF) |
| 14 | Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis | 1.2 | 5 | Citations (PDF) |
| 15 | Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6–11 years with severe atopic dermatitis | 1.8 | 2 | Citations (PDF) |
| 16 | Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines | 1.1 | 22 | Citations (PDF) |
| 17 | A real‐world retrospective observational study exploring resource use for secondary care management of moderate‐to‐severe atopic dermatitis in children and adolescents at a single site in Ireland | 0.5 | 0 | Citations (PDF) |
| 18 | Early emollient bathing is associated with subsequent atopic dermatitis in an unselected birth cohort study | 2.8 | 6 | Citations (PDF) |
| 19 | European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation | 13.9 | 95 | Citations (PDF) |
| 20 | ‘Guidelines are not the issue, access to support and advice is the problem’: a cross-sectional survey of general practitioners referring to paediatric dermatology | 1.2 | 0 | Citations (PDF) |
| 21 | A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis | 9.5 | 26 | Citations (PDF) |
| 22 | Children with atopic dermatitis show increased activity of β‐glucocerebrosidase and stratum corneum levels of glucosylcholesterol that are strongly related to the local cytokine milieu | 1.8 | 17 | Citations (PDF) |
| 23 | Disease characteristics, comorbidities, treatment patterns and quality of life impact in children <12 years old with atopic dermatitis: Interim results from the PEDISTAD Real-World Registry | 1.9 | 17 | Citations (PDF) |
| 24 | Model-Based Meta-Analysis to Optimize Staphylococcus aureus‒Targeted Therapies for Atopic Dermatitis | 2.8 | 11 | Citations (PDF) |
| 25 | Risk factors for distant metastasis in cutaneous squamous cell carcinoma | 1.8 | 10 | Citations (PDF) |
| 26 | The VASCERN-VASCA working group diagnostic and management pathways for severe and/or rare infantile hemangiomas | 1.6 | 7 | Citations (PDF) |
| 27 | Parental atopy and risk of atopic dermatitis in the first two years of life in the BASELINE birth cohort study | 1.1 | 10 | Citations (PDF) |
| 28 | MicroRNA analysis of childhood atopic dermatitis reveals a role for miR‐451a* | 1.8 | 23 | Citations (PDF) |
| 29 | Autosomal recessive hypotrichosis with loose anagen hairs associated with
<i>TKFC</i>
mutations* | 1.8 | 13 | Citations (PDF) |
| 30 | PLACK syndrome resulting from a novel homozygous variant in <i>CAST</i> | 1.1 | 8 | Citations (PDF) |
| 31 | Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis | 9.5 | 98 | Citations (PDF) |
| 32 | Topical corticosteroids normalize both skin and systemic inflammatory markers in infant atopic dermatitis | 1.8 | 31 | Citations (PDF) |
| 33 | The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata | 1.9 | 58 | Citations (PDF) |
| 34 | Shedding light on therapeutics in alopecia and their relevance to COVID-19 | 1.5 | 10 | Citations (PDF) |
| 35 | Meta-Analysis of Mutations in ALOX12B or ALOXE3 Identified in a Large Cohort of 224 Patients | 2.6 | 31 | Citations (PDF) |
| 36 | Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use | 1.9 | 11 | Citations (PDF) |
| 37 | Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome | 3.2 | 65 | Citations (PDF) |
| 38 | A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS) | 5.5 | 30 | Citations (PDF) |
| 39 | Learning from disease registries during a pandemic: Moving toward an international federation of patient registries | 1.5 | 13 | Citations (PDF) |
| 40 | Four childhood atopic dermatitis subtypes identified from trajectory and severity of disease and internally validated in a large UK birth cohort | 1.8 | 32 | Citations (PDF) |
| 41 | The Role of the Environment and Exposome in Atopic Dermatitis | 1.4 | 76 | Citations (PDF) |
| 42 | Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials | 52.8 | 462 | Citations (PDF) |
| 43 | Biallelic variants in
<i>RNU12</i>
cause CDAGS syndrome | 3.9 | 17 | Citations (PDF) |
| 44 | Efficacy of Sirolimus in Patients Requiring Tracheostomy for Life-Threatening Lymphatic Malformation of the Head and Neck: A Report From the European Reference Network | 1.8 | 14 | Citations (PDF) |
| 45 | Dermatology COVID-19 Registries | 2.0 | 16 | Citations (PDF) |
| 46 | Behavioral consequences at 5 y of neonatal iron deficiency in a low-risk maternal–infant cohort | 4.9 | 20 | Citations (PDF) |
| 47 | <i>Staphylococcus aureus</i>
binds to the N-terminal region of corneodesmosin to adhere to the stratum corneum in atopic dermatitis | 7.6 | 55 | Citations (PDF) |
| 48 | Clinical examination for hyperlinear palms to determine filaggrin genotype: A diagnostic test accuracy study | 2.5 | 9 | Citations (PDF) |
| 49 | The exposome in atopic dermatitis | 9.5 | 147 | Citations (PDF) |
| 50 | The role of filaggrin in atopic dermatitis and allergic disease | 1.1 | 264 | Citations (PDF) |
| 51 | <i>RASA1</i>mosaic mutations in patients with capillary malformation-arteriovenous malformation | 3.9 | 63 | Citations (PDF) |
| 52 | TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema | 1.8 | 19 | Citations (PDF) |
| 53 | Filaggrin Expression and Processing Deficiencies Impair Corneocyte Surface Texture and Stiffness in Mice | 2.3 | 37 | Citations (PDF) |
| 54 | The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group | 1.8 | 173 | Citations (PDF) |
| 55 | The impact of short‐term predominate breastfeeding on cognitive outcome at 5 years | 1.7 | 21 | Citations (PDF) |
| 56 | What is the evidence for interactions between filaggrin null mutations and environmental exposures in the aetiology of atopic dermatitis? A systematic review | 1.8 | 33 | Citations (PDF) |
| 57 | The Immunomodulatory Metabolite Itaconate Modifies NLRP3 and Inhibits Inflammasome Activation | 26.2 | 502 | Citations (PDF) |
| 58 | Atopic dermatitis | 52.8 | 1,558 | Citations (PDF) |
| 59 | Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology | 2.0 | 11 | Citations (PDF) |
| 60 | International collaboration and rapid harmonization across dermatologic COVID-19 registries | 1.9 | 14 | Citations (PDF) |
| 61 | The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata | 1.9 | 169 | Citations (PDF) |
| 62 | In vivo Raman spectroscopy discriminates between FLG loss-of-function carriers vs wild-type in day 1-4 neonates | 1.1 | 12 | Citations (PDF) |
| 63 | The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema* | 1.8 | 37 | Citations (PDF) |
| 64 | Global reporting of cases of COVID‐19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic | 1.8 | 18 | Citations (PDF) |
| 65 | Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis | 1.0 | 13 | Citations (PDF) |
| 66 | Changes in nano-mechanical properties of human epidermal cornified cells in children with atopic dermatitis | 1.0 | 1 | Citations (PDF) |
| 67 | The NLRP3 inhibitor MCC950 inhibits IL-1β production in PBMC from 19 patients with Cryopyrin-Associated Periodic Syndrome and in 2 patients with Schnitzler’s Syndrome | 1.0 | 8 | Citations (PDF) |
| 68 | <scp>TRE</scp>
atment of
<scp>AT</scp>
opic eczema (
<scp>TREAT</scp>
) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries | 1.8 | 32 | Citations (PDF) |
| 69 | Systemic and stratum corneum biomarkers of severity in infant atopic dermatitis include markers of innate and T helper cell‐related immunity and angiogenesis | 1.8 | 94 | Citations (PDF) |
| 70 | Clinical and genetic differences between pustular psoriasis subtypes | 6.2 | 232 | Citations (PDF) |
| 71 | Report from the National Institute of Allergy and Infectious Diseases workshop on “Atopic dermatitis and the atopic march: Mechanisms and interventions” | 6.2 | 178 | Citations (PDF) |
| 72 | <scp>TRE</scp>
atment of
<scp>AT</scp>
opic eczema (
<scp>TREAT</scp>
) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries | 1.8 | 34 | Citations (PDF) |
| 73 | Dermatological manifestations of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis (
<scp>POIKTMP</scp>
): a case series of 28 patients | 1.8 | 9 | Citations (PDF) |
| 74 | Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL‐1β | 9.5 | 68 | Citations (PDF) |
| 75 | The relationship between IGF-I and -II concentrations and body composition at birth and over the first 2 months | 2.4 | 5 | Citations (PDF) |
| 76 | Disease trajectories in childhood atopic dermatitis: an update and practitioner's guide | 1.8 | 66 | Citations (PDF) |
| 77 | Next-generation anti–Staphylococcus aureus vaccines: A potential new therapeutic option for atopic dermatitis? | 6.2 | 24 | Citations (PDF) |
| 78 | The atopic march and atopic multimorbidity: Many trajectories, many pathways | 6.2 | 381 | Citations (PDF) |
| 79 | The microbiome in patients with atopic dermatitis | 6.2 | 445 | Citations (PDF) |
| 80 | Catalogue of inherited disorders found among the Irish Traveller population | 3.9 | 27 | Citations (PDF) |
| 81 | A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT) | 1.8 | 21 | Citations (PDF) |
| 82 | Early-life regional and temporal variation in filaggrin-derived natural moisturizing factor, filaggrin-processing enzyme activity, corneocyte phenotypes and plasmin activity: implications for atopic dermatitis | 1.8 | 50 | Citations (PDF) |
| 83 | Iron status, body size, and growth in the first 2 years of life | 2.8 | 25 | Citations (PDF) |
| 84 | The spectrum of manifestations in desmoplakin gene ( DSP ) spectrin repeat 6 domain mutations: Immunophenotyping and response to ustekinumab | 1.9 | 73 | Citations (PDF) |
| 85 | Staphylococcus aureus and Atopic Dermatitis: A Complex and Evolving Relationship | 8.3 | 447 | Citations (PDF) |
| 86 | Antenatal Vitamin D Status Is Not Associated with Standard Neurodevelopmental Assessments at Age 5 Years in a Well-Characterized Prospective Maternal-Infant Cohort | 3.0 | 20 | Citations (PDF) |
| 87 | Exome Sequencing and Rare Variant Analysis Reveals Multiple Filaggrin Mutations in Bangladeshi Families with Atopic Eczema and Additional Risk Genes | 2.3 | 40 | Citations (PDF) |
| 88 | Response to “Comment on: ‘When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council’” | 1.9 | 2 | Citations (PDF) |
| 89 | The widespread use of topical antimicrobials enriches for resistance in<i>Staphylococcus aureus</i>isolated from patients with atopic dermatitis | 1.8 | 49 | Citations (PDF) |
| 90 | Adhesion of Staphylococcus aureus to Corneocytes from Atopic Dermatitis Patients Is Controlled by Natural Moisturizing Factor Levels | 4.4 | 79 | Citations (PDF) |
| 91 | Antenatal vitamin D exposure and childhood eczema, food allergy, asthma and allergic rhinitis at 2 and 5 years of age in the atopic disease‐specific Cork <scp>BASELINE</scp> Birth Cohort Study | 9.5 | 39 | Citations (PDF) |
| 92 | Atopic dermatitis | 50.7 | 1,581 | Citations (PDF) |
| 93 | The International TREatment of ATopic Eczema (TREAT) Registry Taskforce: An Initiative to Harmonize Data Collection across National Atopic Eczema Photo- and Systemic Therapy Registries | 2.3 | 29 | Citations (PDF) |
| 94 | Clumping Factor B Promotes Adherence of Staphylococcus aureus to Corneocytes in Atopic Dermatitis | 2.7 | 101 | Citations (PDF) |
| 95 | Vitamin D metabolite concentrations in umbilical cord blood serum and associations with clinical characteristics in a large prospective mother-infant cohort in Ireland | 2.4 | 61 | Citations (PDF) |
| 96 | Mathematical modeling of atopic dermatitis reveals “double-switch” mechanisms underlying 4 common disease phenotypes | 6.2 | 61 | Citations (PDF) |
| 97 | Microcytosis is associated with low cognitive outcomes in healthy 2-year-olds in a high-resource setting | 2.5 | 8 | Citations (PDF) |
| 98 | Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center | 1.1 | 39 | Citations (PDF) |
| 99 | When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema Council | 1.9 | 216 | Citations (PDF) |
| 100 | Iron intakes and status of 2‐year‐old children in the Cork BASELINE Birth Cohort Study | 2.8 | 27 | Citations (PDF) |
| 101 | Blue Rubber Bleb Nevus (BRBN) Syndrome Is Caused by Somatic TEK (TIE2) Mutations | 2.3 | 197 | Citations (PDF) |
| 102 | Skin microbiome before development of atopic dermatitis: Early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year | 6.2 | 333 | Citations (PDF) |
| 103 | <scp>SVEP</scp>1 plays a crucial role in epidermal differentiation | 2.8 | 36 | Citations (PDF) |
| 104 | Variation in iodine food composition data has a major impact on estimates of iodine intake in young children | 2.8 | 8 | Citations (PDF) |
| 105 | AP1S3 Mutations Cause Skin Autoinflammation by Disrupting Keratinocyte Autophagy and Up-Regulating IL-36 Production | 2.3 | 147 | Citations (PDF) |
| 106 | Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes | 6.2 | 195 | Citations (PDF) |
| 107 | Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity | 6.2 | 139 | Citations (PDF) |
| 108 | Neonatal adiposity increases the risk of atopic dermatitis during the first year of life | 6.2 | 36 | Citations (PDF) |
| 109 | Low vitamin D deficiency in Irish toddlers despite northerly latitude and a high prevalence of inadequate intakes | 3.5 | 25 | Citations (PDF) |
| 110 | Update on Epidemiology, Diagnosis, and Disease Course of Atopic Dermatitis | 0.8 | 41 | Citations (PDF) |
| 111 | Review of Critical Issues in the Pathogenesis of Atopic Dermatitis | 0.8 | 11 | Citations (PDF) |
| 112 | Assessing the New and Emerging Treatments for Atopic Dermatitis | 0.8 | 14 | Citations (PDF) |
| 113 | The Changing Paradigm of Atopic Dermatitis Therapy | 0.8 | 1 | Citations (PDF) |
| 114 | Kasabach-Merritt syndrome, kaposiform haemangioendothelioma and platelet blockade | 2.4 | 5 | Citations (PDF) |
| 115 | Expanding the clinical spectrum of hereditary fibrosing poikiloderma with tendon contractures, myopathy and pulmonary fibrosis due to FAM111B mutations | 3.2 | 46 | Citations (PDF) |
| 116 | Recent advances in the pathobiology and management of Kasabach–Merritt phenomenon | 2.4 | 120 | Citations (PDF) |
| 117 | DOCK8 primary immunodeficiency syndrome | 52.8 | 4 | Citations (PDF) |
| 118 | Use of ruxolitinib to successfully treat chronic mucocutaneous candidiasis caused by gain-of-function signal transducer and activator of transcription 1 (STAT1) mutation | 6.2 | 163 | Citations (PDF) |
| 119 | Genome-wide Comparative Analysis of Atopic Dermatitis and Psoriasis Gives Insight into Opposing Genetic Mechanisms | 6.5 | 184 | Citations (PDF) |
| 120 | Cohort profile: The Cork BASELINE Birth Cohort Study: Babies after SCOPE: Evaluating the Longitudinal Impact on Neurological and Nutritional Endpoints | 5.1 | 64 | Citations (PDF) |
| 121 | Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin | 6.2 | 118 | Citations (PDF) |
| 122 | Activating CARD14 Mutations Are Associated with Generalized Pustular Psoriasis but Rarely Account for Familial Recurrence in Psoriasis Vulgaris | 2.3 | 108 | Citations (PDF) |
| 123 | Adherence with early infant feeding and complementary feeding guidelines in the Cork BASELINE Birth Cohort Study | 2.2 | 35 | Citations (PDF) |
| 124 | IL36RN mutations define a severe autoinflammatory phenotype of generalized pustular psoriasis | 6.2 | 137 | Citations (PDF) |
| 125 | Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis | 6.2 | 108 | Citations (PDF) |
| 126 | Crossing Barriers; Restoring Barriers? Filaggrin Protein Replacement Takes a Bow | 2.3 | 10 | Citations (PDF) |
| 127 | Insight into<i>IKBKG</i>/<i>NEMO</i>Locus: Report of New Mutations and Complex Genomic Rearrangements Leading to Incontinentia Pigmenti Disease | 3.9 | 85 | Citations (PDF) |
| 128 | A longitudinal study of skin barrier function in pregnancy and the postnatal period | 0.7 | 5 | Citations (PDF) |
| 129 | South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin | 6.2 | 72 | Citations (PDF) |
| 130 | siRNA Silencing of the Mutant Keratin 12 Allele in Corneal Limbal Epithelial Cells Grown From Patients With Meesmann's Epithelial Corneal Dystrophy 2014, 55, 3352 | | 33 | Citations (PDF) |
| 131 | Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis | 6.2 | 132 | Citations (PDF) |
| 132 | Systemic therapies for severe atopic dermatitis in children and adults | 6.2 | 55 | Citations (PDF) |
| 133 | Tmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjects | 6.2 | 151 | Citations (PDF) |
| 134 | Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status | 6.2 | 58 | Citations (PDF) |
| 135 | The multifunctional role of filaggrin in allergic skin disease | 6.2 | 392 | Citations (PDF) |
| 136 | A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis | 3.0 | 223 | Citations (PDF) |
| 137 | Use of Systemic Corticosteroids in Management of a Large Congenital Haemangioma of the Scalp | 1.1 | 2 | Citations (PDF) |
| 138 | <i>RASA1</i>Mutations and Associated Phenotypes in 68 Families with Capillary Malformation-Arteriovenous Malformation | 3.9 | 267 | Citations (PDF) |
| 139 | Newborn Transepidermal Water Loss Values: A Reference Dataset | 1.1 | 45 | Citations (PDF) |
| 140 | Mutations in the SASPase Gene (ASPRV1) Are Not Associated with Atopic Eczema or Clinically Dry Skin | 2.3 | 11 | Citations (PDF) |
| 141 | Intragenic Copy Number Variation within Filaggrin Contributes to the Risk of Atopic Dermatitis with a Dose-Dependent Effect | 2.3 | 196 | Citations (PDF) |
| 142 | Filaggrin loss-of-function mutations are associated with enhanced expression of IL-1 cytokines in the stratum corneum of patients with atopic dermatitis and in a murine model of filaggrin deficiency | 6.2 | 253 | Citations (PDF) |
| 143 | Skin involvement in <scp>D</scp>own syndrome transient abnormal myelopoiesis | 2.4 | 2 | Citations (PDF) |
| 144 | Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy | 6.2 | 454 | Citations (PDF) |
| 145 | Filaggrin Mutations Associated with Skin and Allergic Diseases | 43.7 | 1,111 | Citations (PDF) |
| 146 | Development of Allele-Specific Therapeutic siRNA in Meesmann Epithelial Corneal Dystrophy | 2.4 | 42 | Citations (PDF) |
| 147 | PHACE syndrome: MRI of intracerebral vascular anomalies and clinical findings in a series of 12 patients | 1.9 | 27 | Citations (PDF) |
| 148 | Identification of a novel <i>C16orf57</i> mutation in Athabaskan patients with Poikiloderma with Neutropenia | 1.5 | 36 | Citations (PDF) |
| 149 | Cantú syndrome: Report of nine new cases and expansion of the clinical phenotype | 1.5 | 69 | Citations (PDF) |
| 150 | Gender- and Gestational Age–Specific Body Fat Percentage at Birth | 4.7 | 108 | Citations (PDF) |
| 151 | Deletion of Late Cornified Envelope 3B and 3C Genes Is Not Associated with Atopic Dermatitis | 2.3 | 29 | Citations (PDF) |
| 152 | Chromosome 11q13.5 variant associated with childhood eczema: An effect supplementary to filaggrin mutations | 6.2 | 60 | Citations (PDF) |
| 153 | Raman profiles of the stratum corneum define 3 filaggrin genotype–determined atopic dermatitis endophenotypes | 6.2 | 145 | Citations (PDF) |
| 154 | Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus | 6.2 | 230 | Citations (PDF) |
| 155 | Carrier Status for the Common R501X and 2282del4 Filaggrin Mutations Is Not Associated with Hearing Phenotypes in 5377 Children from the ALSPAC Cohort | 2.4 | 9 | Citations (PDF) |
| 156 | Towards a unified classification of the ectodermal dysplasias: Opportunities outweigh challenges | 1.5 | 27 | Citations (PDF) |
| 157 | Mediastinal and Neck Kaposiform Hemangioendothelioma: Report of Three Cases | 1.1 | 33 | Citations (PDF) |
| 158 | Meta-analysis of filaggrin polymorphisms in eczema and asthma: Robust risk factors in atopic disease | 6.2 | 398 | Citations (PDF) |
| 159 | Loss-of-Function Mutations in the Filaggrin Gene Lead to Reduced Level of Natural Moisturizing Factor in the Stratum Corneum | 2.3 | 287 | Citations (PDF) |
| 160 | Successful Treatment of Florid Cutaneous Warts with Intravenous Cidofovir in an 11‐Year‐Old Girl | 1.1 | 20 | Citations (PDF) |
| 161 | The burden of disease associated with filaggrin mutations: A population-based, longitudinal birth cohort study | 6.2 | 329 | Citations (PDF) |
| 162 | Filaggrin mutations, atopic eczema, hay fever, and asthma in children | 6.2 | 395 | Citations (PDF) |
| 163 | Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk | 6.2 | 84 | Citations (PDF) |
| 164 | Filaggrin in atopic dermatitis | 6.2 | 473 | Citations (PDF) |
| 165 | Atopic Eczema and the Filaggrin Story | 0.8 | 87 | Citations (PDF) |
| 166 | The role of filaggrin loss-of-function mutations in atopic dermatitis | 2.4 | 50 | Citations (PDF) |
| 167 | Toward a major risk factor for atopic eczema: Meta-analysis of filaggrin polymorphism data | 6.2 | 219 | Citations (PDF) |
| 168 | A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita | 2.3 | 50 | Citations (PDF) |
| 169 | Filaggrin Null Alleles Are Not Associated with Psoriasis | 2.3 | 45 | Citations (PDF) |
| 170 | Response to IL‐1‐Receptor Antagonist in a Child with Familial Cold Autoinflammatory Syndrome | 1.1 | 29 | Citations (PDF) |
| 171 | Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations | 6.2 | 593 | Citations (PDF) |
| 172 | Prevalent and Rare Mutations in the Gene Encoding Filaggrin Cause Ichthyosis Vulgaris and Predispose Individuals to Atopic Dermatitis | 2.3 | 220 | Citations (PDF) |
| 173 | Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED) in the Irish Population | 0.9 | 59 | Citations (PDF) |
| 174 | Mapping of two genetic loci for autosomal dominant hidradenitis suppurativa | 2.8 | 4 | Citations (PDF) |
| 175 | Inherited defects in keratins | 1.5 | 30 | Citations (PDF) |
| 176 | An unusual N-terminal deletion of the laminin 3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome | 3.0 | 112 | Citations (PDF) |
| 177 | Comparative
<i>PRKAR1A</i>
genotype–phenotype analyses in humans with Carney complex and
<i>prkar1a</i>
haploinsufficient mice | 7.6 | 161 | Citations (PDF) |
| 178 | Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non-Navajo patients | 0.5 | 37 | Citations (PDF) |
| 179 | An unusual N-terminal deletion of the laminin 3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome | 3.0 | 130 | Citations (PDF) |
| 180 | Inherited disorders of keratinization | 0.1 | 1 | Citations (PDF) |
| 181 | Netherton Syndrome: Disease Expression and Spectrum of SPINK5 Mutations in 21 Families | 2.3 | 192 | Citations (PDF) |
| 182 | Inherited disorders of keratinization | 0.1 | 3 | Citations (PDF) |
| 183 | Ocular Surface Reconstruction in LOGIC Syndrome by Amniotic Membrane Transplantation | 1.8 | 16 | Citations (PDF) |
| 184 | Hair on a gene string: recent advances in understanding the molecular genetics of hair loss | 1.2 | 25 | Citations (PDF) |
| 185 | Hay-Wells syndrome is caused by heterozygous missense mutations in the SAM domain of p63 | 3.0 | 346 | Citations (PDF) |
| 186 | Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome | 26.1 | 865 | Citations (PDF) |
| 187 | Identification of Novel Mutations in Basic Hair Keratins hHb1 and hHb6 in Monilethrix: Implications for Protein Structure and Clinical Phenotype | 2.3 | 60 | Citations (PDF) |
| 188 | Mutations in Keratin K9 in Kindreds with Epidermolytic Palmoplantar Keratoderma and Epidemiology in Northern Ireland | 2.3 | 47 | Citations (PDF) |
| 189 | A Missense Mutation in the Zinc-Finger Domain of the Human Hairless Gene Underlies Congenital Atrichia in a Family of Irish Travellers | 6.5 | 79 | Citations (PDF) |
| 190 | A Mutation in the V1 Domain of Keratin 5 Causes Epidermolysis Bullosa Simplex with Mottled Pigmentation | 2.3 | 49 | Citations (PDF) |
| 191 | A Novel Mutation in the Helix Termination Peptide of Keratin 5 Causing Epidermolysis Bullosa Simplex Dowling–Meara | 2.3 | 19 | Citations (PDF) |
| 192 | Focal dermal hypoplasia (Goltz syndrome) associated with intestinal malrotation and mediastinal dextroposition 1996, 62, 213-215 | | 19 | Citations (PDF) |
| 193 | Kaposi sarcoma in an patient with atopic dermatitis treated with ciclosporin | 0.4 | 6 | Citations (PDF) |
